{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T08:48:03Z","timestamp":1777884483503,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.bmc.2026.118604","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T16:38:57Z","timestamp":1771519137000},"page":"118604","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design, synthesis, and activity evaluation of novel potential PPAR\u03b1 agonists"],"prefix":"10.1016","volume":"136","author":[{"given":"Xiaoqian","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weinan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jixuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingyong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Likun","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhili","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2026.118604_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154338","article-title":"The role of peroxisome proliferator-activated receptors (PPAR) in immune responses","volume":"114","author":"Christofides","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.bmc.2026.118604_bb0010","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1021\/acs.jcim.9b00838","article-title":"Discovery of novel peroxisome proliferator-activated receptor \u03b1 (PPAR\u03b1) agonists by virtual screening and biological evaluation","volume":"60","author":"Dai","year":"2020","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.bmc.2026.118604_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114616","article-title":"Potentials of peroxisome proliferator-activated receptor (PPAR) \u03b1, \u03b2\/\u03b4, and \u03b3: an in-depth and comprehensive review of their molecular mechanisms, cellular signalling, immune responses and therapeutic implications in multiple diseases","volume":"155","author":"Singh","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.bmc.2026.118604_bb0020","doi-asserted-by":"crossref","first-page":"256","DOI":"10.7150\/ijms.48123","article-title":"Upregulation of peroxisome proliferator-activated receptor-\u03b1 and the lipid metabolism pathway promotes carcinogenesis of ampullary cancer","volume":"18","author":"Wang","year":"2021","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.bmc.2026.118604_bb0025","article-title":"shRNA-mediated PPAR\u03b1 knockdown in human glioma stem cells reduces in vitro proliferation and inhibits orthotopic xenograft tumour growth","author":"Haynes","year":"2018","journal-title":"J Pathol"},{"key":"10.1016\/j.bmc.2026.118604_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14030795","article-title":"A double-negative feedback interaction between miR-21 and PPAR-\u03b1 in clear renal cell carcinoma","author":"Goujon","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.bmc.2026.118604_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2006.10.027","article-title":"Activation of PPAR\u03b1 lowers synthesis and concentration of cholesterol by reduction of nuclear SREBP-2","author":"K\u00f6nig","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bmc.2026.118604_bb0040","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkq012","article-title":"Profiling of promoter occupancy by PPAR\u03b1 in human hepatoma cells via ChIP-chip analysis","author":"van der Meer","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bmc.2026.118604_bb0045","article-title":"The hsa-miR-214-3p\/ATGL axis regulates aberrant lipolysis to promote acute myeloid leukemia progression via PPAR\u03b1 in vitro","author":"Li","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bmc.2026.118604_bb0050","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-63579-3","article-title":"Hepatocyte-specific deletion of Ppar\u03b1 promotes NAFLD in the context of obesity","author":"R\u00e9gnier","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2026.118604_bb0055","doi-asserted-by":"crossref","unstructured":"Roy, A.; Jana, M.; Kundu, M.; Corbett, Grant T.; Rangaswamy, Suresh B.; Mishra, Rama K.; Luan, C.-H.; Gonzalez, frank J.; Pahan, K. HMG-CoA reductase inhibitors bind to PPAR\u03b1 to upregulate Neurotrophin expression in the brain and improve memory in mice. Cell Metab DOI: https:\/\/doi.org\/10.1016\/j.cmet.2015.05.022.","DOI":"10.1016\/j.cmet.2015.05.022"},{"key":"10.1016\/j.bmc.2026.118604_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.fbio.2025.107272","article-title":"Natural products as ligands of peroxisome proliferator-activated receptor alpha for the inhibition of obesity and non-alcoholic fatty liver disease","volume":"71","author":"Hou","year":"2025","journal-title":"Food Biosci"},{"key":"10.1016\/j.bmc.2026.118604_bb0065","article-title":"Peroxisome proliferator-activated receptor \u03b1 and \u03b3 agonists together with TGF-\u03b2 convert human CD4+CD25- T cells into functional Foxp3+ regulatory T cells","author":"Lei","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.bmc.2026.118604_bb0070","doi-asserted-by":"crossref","DOI":"10.2337\/diabetes.48.8.1593","article-title":"Mechanism responsible for inactivation of skeletal muscle pyruvate dehydrogenase complex in starvation and diabetes","author":"Wu","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.bmc.2026.118604_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/antiox14070891","article-title":"Pemafibrate ameliorates Steatotic liver disease regardless of endothelial dysfunction in mice","author":"Hara","year":"2025","journal-title":"Antioxidants"},{"key":"10.1016\/j.bmc.2026.118604_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2016.09.001","article-title":"In vitro metabolism of fenofibric acid by carbonyl reducing enzymes","author":"Mal\u00e1tkov\u00e1","year":"2016","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.bmc.2026.118604_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.apsb.2017.05.005","article-title":"The potential of natural products for targeting PPAR\u03b1","author":"Rigano","year":"2017","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.bmc.2026.118604_bb0090","doi-asserted-by":"crossref","DOI":"10.1021\/acsmedchemlett.8b00574","article-title":"Novel Phenyldiazenyl fibrate analogues as PPAR \u03b1\/\u03b3\/\u03b4 Pan-agonists for the amelioration of metabolic syndrome","author":"Giampietro","year":"2019","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmc.2026.118604_bb0095","doi-asserted-by":"crossref","DOI":"10.2337\/db22-474-P","article-title":"474-P: efficacy of Saroglitazar on diabetes Dyslipidemia with higher triglyceride","author":"Sinha","year":"2022","journal-title":"Diabetes"},{"key":"10.1016\/j.bmc.2026.118604_bb0100","article-title":"Efficacy and safety of elafibranor in primary biliary cholangitis","author":"Kowdley","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmc.2026.118604_bb0105","doi-asserted-by":"crossref","DOI":"10.1007\/s40265-017-0818-x","article-title":"Pemafibrate: first global approval","author":"Blair","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.bmc.2026.118604_bb0110","article-title":"Bezafibrate in primary biliary cholangitis","author":"Jones","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmc.2026.118604_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20225682","article-title":"Gene expression profiles induced by a novel selective peroxisome proliferator-activated receptor \u03b1 modulator (SPPARM\u03b1) Pemafibrate","author":"Sasaki","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2026.118604_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2016.00005","article-title":"Fenofibrate induces ketone body production in melanoma and glioblastoma cells","author":"Grabacka","year":"2016","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.bmc.2026.118604_bb0125","article-title":"PPAR\u03b1-ERR\u03b1 crosstalk mitigates metabolic dysfunction-associated steatotic liver disease progression","author":"Antwi","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.bmc.2026.118604_bb0130","doi-asserted-by":"crossref","DOI":"10.1096\/fj.09-149765","article-title":"Palmitoylation of ketogenic enzyme HMGCS2 enhances its interaction with PPARand transcription at the Hmgcs2 PPRE","author":"Kostiuk","year":"2010","journal-title":"FASEB J"},{"key":"10.1016\/j.bmc.2026.118604_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101727","article-title":"PPAR\u03b1 ligand-binding domain structures with endogenous fatty acids and fibrates","author":"Kamata","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.bmc.2026.118604_bb0140","article-title":"Identification of 3H-benzo[b] [1,4] diazepine derivatives as PPAR\u03b1 agonists by in silico studies and biochemical evaluation","author":"Li","year":"2023","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.bmc.2026.118604_bb0145","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-024-02816-z","article-title":"Downregulation of HMGCS2 mediated AECIIs lipid metabolic alteration promotes pulmonary fibrosis by activating fibroblasts","author":"Yang","year":"2024","journal-title":"Respir Res"},{"key":"10.1016\/j.bmc.2026.118604_bb0150","article-title":"Peroxisome proliferator-activated receptor alpha induces hepatic expression of the human bile acid glucuronidating UDP-glucuronosyltransferase 2B4 enzyme","author":"Barbier","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2026.118604_bb0155","doi-asserted-by":"crossref","DOI":"10.1038\/347645a0","article-title":"Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators","author":"Issemann","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2026.118604_bb0160","doi-asserted-by":"crossref","DOI":"10.1002\/j.1460-2075.1992.tb05072.x","article-title":"The mouse peroxisome proliferator activated receptor recognizes a response element in the 5\u2032 flanking sequence of the rat acyl CoA oxidase gene","author":"Tugwood","year":"1992","journal-title":"EMBO J"},{"key":"10.1016\/j.bmc.2026.118604_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116193","article-title":"Discovery of novel modulators for the PPAR\u03b1 (peroxisome proliferator activated receptor \u03b1): potential therapies for nonalcoholic fatty liver disease","author":"Yu","year":"2021","journal-title":"Bioorg Med Chem"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096808962600060X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096808962600060X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:27:01Z","timestamp":1777602421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096808962600060X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":33,"alternative-id":["S096808962600060X"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118604","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and activity evaluation of novel potential PPAR\u03b1 agonists","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118604","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118604"}}